A novel approach to prostate cancer gene therapy: tageting neurotensin receptors with baculovirus
Prostate cancer is now the most commonly diagnosed male malignancy in the United Kingdom. Traditional treatments provide only temporary resolution of disease, with a more aggressive, androgen-independent form recurring after 18-20 months of initial therapy, which is very difficult to treat. This rec...
| Main Author: | |
|---|---|
| Published: |
University of York
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.489206 |